Also: Johnson & Johnson says its lung cancer drug significantly extended survivalJanuary 7, 2025Check out STAT+Sponsored By Mario Tama/Getty Images STAT+ | Johnson & Johnson says its lung cancer drug significantly extended survival The J&J bispecific antibody, paired with a Janssen drug, has the potential to become standard treatment for non-small lung cancer patients. By Angus Chen Surgeon general calls for labels warning of cancer risk on alcohol Vivek Murthy's call reflects a growing body of research tying alcohol consumption, even in limited amounts, to increased chances of cancer. By Andrew Joseph STAT+ | The surgeon general wants the U.S. to know alcohol causes cancer. Plenty stands in his way Vivek Murthy will have to rely on Congress and the next administration to add warnings about cancer risks to alcohol labels. By Isabella Cueto More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments